Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulation

NCT05032807 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Absorption; Chemicals

Interventions

DRUG: Standard formulation
DRUG: Novel formulation

Sponsor

King's College London